CTK Biotech has obtained the CE mark for our OnSite COVID-19 Ag Self Test. CTK will begin shipping this new test to the countries that accept the CE mark this month.
The OnSite COVID-19 Ag Self Test is a single-use lateral flow immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasal swab specimens from individuals suspected of COVID-19. The test is designed for use with self-collected samples within the first 7 days post-onset of symptoms, as an aid in identifying SARS-CoV-2 infection.
With over 20 years in infectious disease diagnostics, CTK has manufactured a line-up of professional use COVID-19 diagnostic tools and is proud to offer the world the addition of a launched COVID-19 Ag Self Test.